JYNT - Joint reports Q2 operating highlights

2023-08-10 17:45:36 ET

• Joint press release ( NASDAQ: JYNT ): Q2 system-wide Sales Grew 13% to $120.1 Million
• Unrestricted Cash $13.6 Million at June 30, 2023, Compared to $9.7 Million at December 31, 2022
• Increased Clinics to 890 at June 30, 2023 and Achieved the 900 Clinic Milestone in August 2023.
• Sold 21 franchise licenses, compared to 17 in Q1 2023 and 24 in Q2 2022.
• Due to ongoing quarterly review procedures being performed in conjunction with The Joint’s independent public accounting firm, management has postponed the issuance of its second quarter financial results as of June 30, 2023.

For further details see: